This article refers to:
The Editorial by Marco Puzzoni, Pina Ziranu, Laura Demurtas, Eleonora Lai, Stefano Mariani, Nicole Liscia, Paolo Soro, Andrea Pretta, Valentino Impera, Silvia Camera, Francesca Musio, Mara Persano, Clelia Donisi, Simona Tolu, Francesca Balconi & Mario Scartozzi, ‘Why precision medicine should be applied across the continuum of care for metastatic colorectal cancer patients’, which appeared in the January 2020 issue of Future Oncology 16(02), 4337–4339 (2020), was published with a grammatical error in the title, which has now been rectified.
The authors and editors of Future Oncology would like to sincerely apologize for any inconvenience or confusion this may have caused our readers.